Business
Partners with University of Westminster
Partners with University of Westminster.
About this update from Iconic Labs Plc
[{"type":"text","content":"\n \nRNS Number : 8590K WideCells Group PLC 27 September 2016 \n\n \n27 September 2016\n \nWideCells Group PLC ('WideCells Group' or 'the Group' or 'the Company') \nPartners with the University of Westminster to Deliver Online Courses in Stem Cell Technology\n \nWideCells Group PLC, the healthcare services company focused on collecting and storing stem cells and providing ground breaking insurance for stem cell treatment, is pleased to announce that its R&D and training development division, WideAcademy, has finalised its syllabus of short courses focused on educating healthcare professionals on the benefits of stem cell storage and treatment. This will provide the Company with a new revenue stream, on commencement of the courses.\n \nThe ten short courses are currently being developed alongside the University of Westminster and are anticipated to drive uptake of the Group's stem cell storage and healthcare services. Jointly overseen by WideCells Group's Chief Scientific Officer and Dean of WideAcademy, Dr. Peter Hollands, Dr. Emanuela Volpi, Reader in Biomedical Science and Dr. John Murphy, Head of Biomedical Science, both from the University of Westminster, the courses will be delivered by a team of healthcare professionals with a high level of expertise in the field. The collaboration between these parties will ensure the quality of WideAcademy's educational materials as well academic peer review of course content. The Company anticipates that the first course will commence in early 2017 with the launch of the rest to be staggered over the next 24 months.\n \nIn conjunction with this, and in line with its strategy to provide excellence in stem cell education and training, WideAcademy is in the process of developing a conference programme for healthcare and medical professionals. WideAcademy will update the market with further details on the conference, anticipated to be held in Brazil in 2017, once a programme has been finalised. South America's cord blood banking services market has experienced exciting growth in recent years, prompting the Company's decision to deliver an event in this market. \n \nWideCells Group CEO, João Andrade, said, \"Our stated strategy is to make stem cell treatment affordable and accessible for families worldwid...